BRM421 Ophthalmic Solution

BRM421 · BRIM Biotechnology Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BRM421 Ophthalmic Solution, covering 2024-07-11 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency